Lawver Teri L bought CLDX
November 10, 2025 · Form 4 insider transaction
Lawver Teri L bought 100,000 shares of Celldex Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
100,000
Price
$0.00
Total value
N/A
InsiderLawver Teri L
RoleOfficer, Director
SecurityISO (right to buy)
Transaction codeA: Grant or award
Transaction dateNovember 10, 2025
Filing dateNovember 12, 2025
Shares owned after100,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.; 25% vest on November 10, 2026 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.